Screening-preventable cervical cancer risks:: Evidence from a nationwide audit in Sweden

被引:297
作者
Andrae, Bengt [1 ]
Kemetli, Levent [2 ]
Sparen, Par [3 ]
Silfverdal, Lena [4 ]
Strander, Bjorn [5 ]
Ryd, Walter [6 ]
Dillner, Joakim [7 ]
Tornberg, Sven [2 ]
机构
[1] Gavle Cent Hosp, Dept Obstet & Gynecol, S-80187 Gavle, Sweden
[2] Karolinska Univ Hosp, Canc Screening Unit, Oncol Ctr M8, Stockholm, Sweden
[3] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[4] Umea Univ Hosp, Dept Obstet & Gynecol, S-90185 Umea, Sweden
[5] Sahlgrens Univ Hosp, Ctr Oncol, Gothenburg, Sweden
[6] Sahlgrens Univ Hosp, Dept Pathol & Clin Cytol, Gothenburg, Sweden
[7] Lund Univ, Dept Med Microbiol, Univ Hosp, Malmo, Sweden
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2008年 / 100卷 / 09期
关键词
D O I
10.1093/jnci/djn099
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The effectiveness of cervical cancer screening programs differs widely in different populations. The reasons for these differences are unclear. Routine and comprehensive audits have been proposed as an ethically required component of screening. We performed a nationwide audit of the effectiveness of the Swedish cervical cancer screening program. Methods We identified all invasive cervical cancer cases that were diagnosed in Sweden from January 1, 1999, through December 31, 2001, and had been reported to the Swedish Cancer Registry (n = 1230 cases). We verified the diagnoses by histopathologic rereview and matched each case subject to five (population-based) age-matched control subjects who were identified from the National Population Register. The Pap smear screening histories for case and control subjects were reviewed for a 6-year period using the National Cervical Cancer Screening Register, which contains data on essentially all relevant cytological and histological diagnoses in Sweden. Odds ratios (ORs), and their 95% confidence intervals (CIs), of cervical cancer according to screening history were calculated in conditional logistic regression models. All statistical tests were two-sided. Results Women who had not had a Pap smear within the recommended screening interval had higher risk of cervical cancer than women who had been screened (OR = 2.52, 95% CI = 2.19 to 2.91). This risk was similarly increased for all age groups (P-homogeneity = .96). The risk for nonsquamous cell cervical cancers (OR = 1.59, 95% CI = 1.20 to 2.11) was also increased. Women who had not had a Pap smear within the recommended screening interval had a particularly high risk of advanced cancers (OR = 4.82, 95% CI = 3.61 to 6.44). Among women who had been screened within the recommended interval, those with abnormal Pap smears had a higher risk of cervical cancer than those with normal smears (OR = 7.55, 95% CI = 5.88 to 9.69) and constituted 11.5% of all women with cervical cancer. Conclusions Nonadherence to screening intervals was the major reason for cervical cancer morbidity. The screening program was equally effective for women of all ages and was also effective against nonsquamous cancers.
引用
收藏
页码:622 / 629
页数:8
相关论文
共 45 条
  • [1] The pap-smear history of women with invasive cervical squamous carcinoma -: A case-control study from Sweden
    Andersson-Ellström, A
    Seidal, T
    Grannas, M
    Hagmar, B
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (03) : 221 - 226
  • [2] Clinical impact of quality assurance in an organized cervical screening program
    Andrae, B
    Smith, P
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1999, 78 (05) : 429 - 435
  • [3] Anttila A, 1999, INT J CANCER, V83, P59, DOI 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO
  • [4] 2-N
  • [5] Trends in cancer of the cervix uteri in Sweden following cytological screening
    Bergström, R
    Sparén, P
    Adami, HO
    [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (01) : 159 - 166
  • [6] The causal relation between human papillomavirus and cervical cancer
    Bosch, FX
    Lorincz, A
    Muñoz, N
    Meijer, CJLM
    Shah, KV
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) : 244 - 265
  • [7] Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening
    Bray, F
    Loos, AH
    McCarron, P
    Weiderpass, E
    Arbyn, M
    Moller, H
    Hakama, M
    Parkin, DM
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (03) : 677 - 686
  • [8] Incidence trends of adenocarcinoma of the cervix in 13 European countries
    Bray, F
    Carstensen, B
    Moller, H
    Zappa, M
    Zakelj, MP
    Lawrence, G
    Hakama, M
    Weiderpass, E
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (09) : 2191 - 2199
  • [9] Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women
    Bulk, S
    Visser, O
    Rozendaal, L
    Verheijen, RHM
    Meijer, CJLM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (06) : 1005 - 1009
  • [10] Changes in cervical cancer incidence after three decades of screening US women less than 30 years old
    Chan, PG
    Sung, HY
    Sawaya, GF
    [J]. OBSTETRICS AND GYNECOLOGY, 2003, 102 (04) : 765 - 773